Although the scientific relevance of the aforementioned cardiovascular risk factor alterations by tirzepatide are going to be assessed within the prepared cardiovascular end result analyze SURPASS-CVOT ( "form":"clinical-demo","attrs": "text":"NCT04255433","term_id":"NCT04255433" NCT04255433), a pre-specified cardiovascular meta-Assessment indicate